126 related articles for article (PubMed ID: 27881017)
21. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
22. [Correlations between serum interleukin-18 (IL-18) level, IL-18 gene promoter polymorphisms and the development of sepsis in children].
Cai LL; Xiang W; Xie YQ; Liao F; Feng XW; Zhang DF; Chen YW; Zhang YM; Huang MJ; Zeng X
Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):9-14. PubMed ID: 20441695
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
24. Effect of CYP17 and PSA gene polymorphisms on prostate cancer risk and circulating PSA levels in the Slovak population.
Sivoňová MK; Dobrota D; Dušenka R; Waczulíková I; Slezák P; Matáková T; Mahmoodová S; Mištuna D; Kliment J
Mol Biol Rep; 2012 Aug; 39(8):7871-80. PubMed ID: 22528335
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
[TBL] [Abstract][Full Text] [Related]
26. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
27. Manganese superoxide dismutase Ile58Thr, catalase C-262T and myeloperoxidase G-463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease.
Tefik T; Kucukgergin C; Sanli O; Oktar T; Seckin S; Ozsoy C
BJU Int; 2013 Aug; 112(4):E406-14. PubMed ID: 23773345
[TBL] [Abstract][Full Text] [Related]
28. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
Chen CH; Gong M; Yi QT; Guo JH
Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
[TBL] [Abstract][Full Text] [Related]
29. The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.
Men T; Yu C; Wang D; Liu F; Li J; Qi X; Yang C; Jiang W; Wei X; Li X; Wang B; Mi J; Tian G
Oncotarget; 2017 Jul; 8(28):45994-46005. PubMed ID: 28526808
[TBL] [Abstract][Full Text] [Related]
30. Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer.
Abed AS; Mokdad-Gargouri R; Raoof WM
Mol Biol Rep; 2023 Feb; 50(2):1157-1165. PubMed ID: 36417078
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.
Huang WJ; Wu LJ; Min ZC; Xu LT; Guo CM; Chen ZP; Lou XJ; Xu B; Lv BD
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706719
[TBL] [Abstract][Full Text] [Related]
32. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
33. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
Eder T; Mayer R; Langsenlehner U; Renner W; Krippl P; Wascher TC; Pummer K; Kapp KS
Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
37. Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer.
Chatrabnous N; Jafarzadeh A; Ghaderi A; Ariafar A; Aminizadeh N; Ghassabi F; Nemati M
Eur Cytokine Netw; 2019 Dec; 30(4):144-150. PubMed ID: 32096476
[TBL] [Abstract][Full Text] [Related]
38. CXCR2 +1208 CT genotype may predict earlier clinical stage at diagnosis in patients with prostate cancer.
Franz JM; Portela P; Salim PH; Berger M; Fernando Jobim L; Roesler R; Jobim M; Schwartsmann G
Cytokine; 2017 Sep; 97():193-200. PubMed ID: 28668699
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 polymorphism and prostate cancer risk in population of Eastern Croatia.
Mandić S; Sudarević B; Marczi S; Horvat V; Cosić I; Mihaljević S; Milicević N; Simunović D; Galić J
Coll Antropol; 2013 Sep; 37(3):907-11. PubMed ID: 24308236
[TBL] [Abstract][Full Text] [Related]
40. [Association of interleukin-18 gene rs1946519 and rs360718 single nucleotide polymorphism with cervical cancer].
Yang HL; Pin BH; Wang Q; Zheng L; Tang W; Qi T; Bao J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1006-8. PubMed ID: 17666338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
